#EMDSerono and #Pfizer Receive US #FDA #BreakthroughTherapyDesignation and Submit Application for #BAVENCIO® for First-Line Maintenance Treatment of Locally Advanced or Metastatic #UrothelialCarcinoma $MRK $PFE https://t.co/WdcKs6oBFE